Drug delivery systems (DDS) are defined as methods by which drugs are delivered to
desired tissues, organs, cells and subcellular organs for drug release and absorption …

Coronavirus disease 2019 (COVID-19), due to infection by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is now causing a global pandemic. Aerosol …

Over the last years, respiratory diseases represent a clinical concern, being included among
the leading causes of death in the world due to the lack of effective lung therapies, mainly …

Understanding the effects mediated by a set of nanoparticle (NP)-bound host biomolecules,
often indicated with the umbrella term of NP corona, is essential in nanomedicine …

The rapid development of nanotechnology is opening a huge world of promising
possibilities in healthcare, but this is also increasing the necessity to study the potential risk …

Particulate matter (PM), which is the primary contributor to air pollution, has become a
pervasive global health threat. When PM enters into a respiratory tract, the first body tissues …

Pulmonary surfactant (PS) has been extensively studied because of its primary role in
mammalian breathing. The deposition of this surface-active material at the alveolar air-water …

Respiratory illnesses are prevalent around the world, and inhalation‐based therapies
provide an attractive, noninvasive means of directly delivering therapeutic agents to their site …

Exposure to nanoparticles (NPs) is plausible in real life due to ambient particulate exposure
or development of nanotechnologies, hence the evaluation of NP toxicity as well as …

Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …